- Home
- Publications
- Publication Search
- Publication Details
Title
State of the Art: ctDNA in Upper Gastrointestinal Malignancies
Authors
Keywords
-
Journal
Cancers
Volume 15, Issue 5, Pages 1379
Publisher
MDPI AG
Online
2023-02-22
DOI
10.3390/cancers15051379
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ESMO Scale for Clinical Actionability of Molecular Targets Driving Targeted Treatment in Patients with Cholangiocarcinoma
- (2022) Helena Verdaguer et al. CLINICAL CANCER RESEARCH
- Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion
- (2022) Debyani Chakravarty et al. JOURNAL OF CLINICAL ONCOLOGY
- Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
- (2022) Laura Izquierdo-Sanchez et al. JOURNAL OF HEPATOLOGY
- Circulating Cell-Free DNA-Based Comprehensive Molecular Analysis of Biliary Tract Cancers Using Next-Generation Sequencing
- (2022) Szilvia Lilla Csoma et al. Cancers
- Circulating miRNA and cell-free DNA as a potential diagnostic tool in early detection of biliary tract cancer: a meta-analysis
- (2022) Aakansha Singh et al. BIOMARKERS
- Circulating Tumor DNA: An Emerging Tool in Gastrointestinal Cancers
- (2022) Olatunji B. Alese et al. American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
- ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group
- (2022) J. Pascual et al. ANNALS OF ONCOLOGY
- Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
- (2022) F. Lordick et al. ANNALS OF ONCOLOGY
- NHS-Galleri Trial Design: Equitable study recruitment tactics for targeted population-level screening with a multi-cancer early detection (MCED) test.
- (2022) Charles Swanton et al. JOURNAL OF CLINICAL ONCOLOGY
- Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer
- (2022) Hedy L. Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic value of plasma circulating tumor DNA fraction across four common cancer types: a real-world outcomes study
- (2022) Z.R. Reichert et al. ANNALS OF ONCOLOGY
- Liquid versus tissue biopsy for detecting actionable alterations according to the ESMO Scale for Clinical Actionability of molecular Targets in patients with advanced cancer: a study from the French National Center for Precision Medicine (PRISM)
- (2022) A. Bayle et al. ANNALS OF ONCOLOGY
- The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer
- (2022) J.E. Berchuck et al. ANNALS OF ONCOLOGY
- Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study
- (2022) Zev A Wainberg et al. LANCET ONCOLOGY
- Current developments in gastric cancer: from molecular profiling to treatment strategy
- (2022) Maria Alsina et al. Nature Reviews Gastroenterology & Hepatology
- Circulating Tumor DNA—A Novel Biomarker of Tumor Progression and Its Favorable Detection Techniques
- (2022) Xiaosha Wen et al. Cancers
- Longitudinal tracking of 97 esophageal adenocarcinomas using liquid biopsy sampling
- (2021) E. Ococks et al. ANNALS OF ONCOLOGY
- Longitudinal analysis of cell-free mutated KRAS and CA 19–9 predicts survival following curative resection of pancreatic cancer
- (2021) Saskia Hussung et al. BMC CANCER
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)
- (2021) Mª A. Gómez-España et al. Clinical & Translational Oncology
- Molecularly targeted therapy for advanced gastrointestinal noncolorectal cancer treatment: how to choose? Past, present, future
- (2021) Olga Nigro et al. ANTI-CANCER DRUGS
- Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial
- (2021) Angela Lamarca et al. LANCET ONCOLOGY
- Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm
- (2021) Yoshiaki Nakamura et al. Nature Reviews Clinical Oncology
- Cell-free DNA copy number variations predict efficacy of immune checkpoint inhibitor-based therapy in hepatobiliary cancers
- (2021) Xu Yang et al. Journal for ImmunoTherapy of Cancer
- Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set
- (2021) E.A. Klein et al. ANNALS OF ONCOLOGY
- SCRUM‐Japan GI‐SCREEN and MONSTAR‐SCREEN: Path to the realization of biomarker‐guided precision oncology in advanced solid tumors
- (2021) Yoshiaki Nakamura et al. CANCER SCIENCE
- Results and molecular correlates from a pilot study of neoadjuvant induction FOLFIRINOX followed by chemoradiation and surgery for gastroesophageal adenocarcinomas
- (2021) Jennifer Y. Wo et al. CLINICAL CANCER RESEARCH
- Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures
- (2021) Maria Arechederra et al. GUT
- Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
- (2021) Jong-Mu Sun et al. LANCET
- First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
- (2021) Yelena Y Janjigian et al. LANCET
- Liquid Biopsy from Bile-Circulating Tumor DNA in Patients with Biliary Tract Cancer
- (2021) Jin-Yi Han et al. Cancers
- Prognostic value of circulating tumour DNA in metastatic pancreatic cancer patients: post-hoc analyses of two clinical trials
- (2021) Daniel Pietrasz et al. BRITISH JOURNAL OF CANCER
- Ultrasensitive and affordable assay for early detection of primary liver cancer using plasma cell‐free DNA fragmentomics
- (2021) Xiangyu Zhang et al. HEPATOLOGY
- Cell-free DNA from bile outperformed plasma as a potential alternative to tissue biopsy in biliary tract cancer
- (2021) Q. Gou et al. ESMO Open
- Preoperative detection of KRAS G12D mutation in ctDNA is a powerful predictor for early recurrence of resectable PDAC patients
- (2020) Shiwei Guo et al. BRITISH JOURNAL OF CANCER
- Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer
- (2020) Fumiaki Watanabe et al. PLoS One
- White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
- (2020) Alessandro Leal et al. Nature Communications
- Kras mutation correlating with circulating regulatory T cells predicts the prognosis of advanced pancreatic cancer patients
- (2020) He Cheng et al. Cancer Medicine
- A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer
- (2020) Alex H. Wagner et al. NATURE GENETICS
- Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer
- (2020) Jian Yang et al. Cell Death & Disease
- Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
- (2020) M.C. Liu et al. ANNALS OF ONCOLOGY
- Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma
- (2020) Mark R. Openshaw et al. BRITISH JOURNAL OF CANCER
- The potential of liquid biopsies in gastrointestinal cancer
- (2020) Chenxi Wu et al. CLINICAL BIOCHEMISTRY
- Circulating tumor DNA is prognostic and potentially predictive of eryaspase efficacy in second-line in patients with advanced pancreatic adenocarcinoma.
- (2020) Jean-Baptiste Bachet et al. CLINICAL CANCER RESEARCH
- Comprehensive Genomic Landscape and Precision Therapeutic Approach in Biliary Tract Cancers
- (2020) Ryosuke Okamura et al. INTERNATIONAL JOURNAL OF CANCER
- Cholangiocarcinoma 2020: the next horizon in mechanisms and management
- (2020) Jesus M. Banales et al. Nature Reviews Gastroenterology & Hepatology
- Non-invasive early detection of cancer four years before conventional diagnosis using a blood test
- (2020) Xingdong Chen et al. Nature Communications
- Circulating Cell-Free DNA-Based Liquid Biopsy Markers for the Non-Invasive Prognosis and Monitoring of Metastatic Pancreatic Cancer
- (2020) Marta Toledano-Fonseca et al. Cancers
- Circulating Tumor DNA as a Potential Marker to Detect Minimal Residual Disease and Predict Recurrence in Pancreatic Cancer
- (2020) Jiahong Jiang et al. Frontiers in Oncology
- Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies
- (2020) Yoshiaki Nakamura et al. NATURE MEDICINE
- Prognostic and predictive impact of circulating tumor DNA in patients with advanced cancers treated with immune checkpoint blockade
- (2020) Qu Zhang et al. Cancer Discovery
- Molecular Profiling in Daily Clinical Practice: Practicalities in Advanced Cholangiocarcinoma and Other Biliary Tract Cancers
- (2020) Angela Lamarca et al. Journal of Clinical Medicine
- EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers
- (2020) Elizabeth C Smyth et al. GUT
- Non-invasive detection of biliary tract cancer by low-coverage whole genome sequencing from plasma cell-free DNA: A prospective cohort study
- (2020) Xiang Wang et al. Translational Oncology
- Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease
- (2020) Daniel V.T. Catenacci et al. Cancer Discovery
- Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases
- (2019) Wiphawan Wasenang et al. Clinical Epigenetics
- Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer
- (2019) Vincent P Groot et al. CLINICAL CANCER RESEARCH
- Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
- (2019) Salah-Eddin Al-Batran et al. LANCET
- Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study
- (2019) Dominic G. Rothwell et al. NATURE MEDICINE
- Detecting and Tracking Circulating Tumour DNA Copy Number Profiles during First Line Chemotherapy in Oesophagogastric Adenocarcinoma
- (2019) Michael Davidson et al. Cancers
- Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer
- (2019) B Lee et al. ANNALS OF ONCOLOGY
- Prospective Observation: Clinical Utility of Plasma Epstein‐Barr‐Virus DNA Load in EBV‐associated Gastric Carcinoma Patients
- (2019) Miao‐Zhen Qiu et al. INTERNATIONAL JOURNAL OF CANCER
- Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma
- (2019) Marin Strijker et al. INTERNATIONAL JOURNAL OF CANCER
- Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
- (2019) Talia Golan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor genomic profiling guides metastatic gastric cancer patients to targeted treatment: The VIKTORY Umbrella Trial
- (2019) Jeeyun Lee et al. Cancer Discovery
- Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma
- (2019) Steven B. Maron et al. CLINICAL CANCER RESEARCH
- Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers
- (2019) Aparna R. Parikh et al. NATURE MEDICINE
- Chromosomal instability of circulating tumor DNA reflect therapeutic responses in advanced gastric cancer
- (2019) Zuhua Chen et al. Cell Death & Disease
- How liquid biopsies can change clinical practice in oncology
- (2019) G Siravegna et al. ANNALS OF ONCOLOGY
- High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
- (2019) Pedram Razavi et al. NATURE MEDICINE
- Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pancreatic cancer
- (2019) Sumitra Mohan et al. Scientific Reports
- Genotyping of circulating tumor DNA in cholangiocarcinoma reveals diagnostic and prognostic information
- (2019) T. J. Ettrich et al. Scientific Reports
- Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer
- (2019) Hitendra Patel et al. Journal of Hematology & Oncology
- Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials
- (2019) Robert C Doebele et al. LANCET ONCOLOGY
- Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients
- (2018) S T Kim et al. ANNALS OF ONCOLOGY
- KRAS mutations in cell-free DNA from preoperative and postoperative sera as a pancreatic cancer marker: a retrospective study
- (2018) Yutaka Nakano et al. BRITISH JOURNAL OF CANCER
- Liquid biopsy of bile for the molecular diagnosis of gallbladder cancer
- (2018) Hideaki Kinugasa et al. CANCER BIOLOGY & THERAPY
- Circulating Tumor DNA as a Sensitive Marker in Patients Undergoing Irreversible Electroporation for Pancreatic Cancer
- (2018) Mao Lin et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Prognostic Implications of Multiplex Detection ofKRASMutations in Cell-Free DNA from Patients with Pancreatic Ductal Adenocarcinoma
- (2018) Min Kyeong Kim et al. CLINICAL CHEMISTRY
- HER2 copy number of circulating tumour DNA functions as a biomarker to predict and monitor trastuzumab efficacy in advanced gastric cancer
- (2018) Haixing Wang et al. EUROPEAN JOURNAL OF CANCER
- Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
- (2018) Seung Tae Kim et al. NATURE MEDICINE
- Diagnostic Value of Circulating Free DNA Integrity and Global Methylation Status in Gall Bladder Carcinoma
- (2018) Swati Kumari et al. PATHOLOGY & ONCOLOGY RESEARCH
- OUP accepted manuscript
- (2018) ANNALS OF ONCOLOGY
- A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
- (2018) J Mateo et al. ANNALS OF ONCOLOGY
- Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer
- (2018) De-Shen Wang et al. GUT
- Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer
- (2018) Vincent Bernard et al. GASTROENTEROLOGY
- Monitoring Tumor Burden in Response to FOLFIRINOX Chemotherapy Via Profiling Circulating Cell-Free DNA in Pancreatic Cancer
- (2018) Tao Wei et al. MOLECULAR CANCER THERAPEUTICS
- Application of Cell-free DNA Analysis to Cancer Treatment
- (2018) Ryan B. Corcoran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of ctDNA to predict prognosis and monitor treatment responses in metastatic pancreatic cancer patients
- (2017) He Cheng et al. INTERNATIONAL JOURNAL OF CANCER
- Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer
- (2017) Marilyn M. Li et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- The evidence framework for precision cancer medicine
- (2017) Jeffrey A. Moscow et al. Nature Reviews Clinical Oncology
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- New Horizons for Precision Medicine in Biliary Tract Cancers
- (2017) Juan W. Valle et al. Cancer Discovery
- Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma
- (2017) Eirini Pectasides et al. Cancer Discovery
- High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
- (2017) Christophe Massard et al. Cancer Discovery
- Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer
- (2017) Patricia Adamo et al. Oncotarget
- Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer
- (2017) Marzia Del Re et al. Scientific Reports
- More deaths from pancreatic cancer than breast cancer in the EU by 2017
- (2016) J. Ferlay et al. ACTA ONCOLOGICA
- Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer
- (2016) Naoto Hadano et al. BRITISH JOURNAL OF CANCER
- Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker
- (2016) Daniel Pietrasz et al. CLINICAL CANCER RESEARCH
- Monitoring the HER2 copy number status in circulating tumor DNA by droplet digital PCR in patients with gastric cancer
- (2016) Katsutoshi Shoda et al. Gastric Cancer
- Quantification of Circulating Free DNA as a Diagnostic Marker in Gall Bladder Cancer
- (2016) Swati Kumari et al. PATHOLOGY & ONCOLOGY RESEARCH
- Polyclonal SecondaryFGFR2Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma
- (2016) Lipika Goyal et al. Cancer Discovery
- Alu–based cell-free DNA: a novel biomarker for screening of gastric cancer
- (2016) Chen Qian et al. Oncotarget
- Clinical relevance of cell-free DNA in gastrointestinal tract malignancy
- (2016) Yuan-Tzu Lan et al. Oncotarget
- Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) M. Ducreux et al. ANNALS OF ONCOLOGY
- Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer
- (2015) Julie Earl et al. BMC CANCER
- Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients
- (2015) S Q Wong et al. BRITISH JOURNAL OF CANCER
- High Levels of Cell-Free Circulating Nucleic Acids in Pancreatic Cancer are Associated With Vascular Encasement, Metastasis and Poor Survival
- (2015) Nidhi Singh et al. CANCER INVESTIGATION
- Five biopsy specimens from the proximal part of the tumor reliably determine HER2 protein expression status in gastric cancer
- (2015) Naoyuki Tominaga et al. Gastric Cancer
- Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer
- (2015) Kjersti Tjensvoll et al. Molecular Oncology
- Genomic spectra of biliary tract cancer
- (2015) Hiromi Nakamura et al. NATURE GENETICS
- Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
- (2015) Razvan Cristescu et al. NATURE MEDICINE
- Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients
- (2015) Mark Sausen et al. Nature Communications
- Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas
- (2015) O. A. Zill et al. Cancer Discovery
- PIK3CA mutation detection in metastatic biliary cancer using cell-free DNA
- (2015) Seung Tae Kim et al. Oncotarget
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion
- (2011) R. Xi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- K-ras mutational status predicts poor prognosis in unresectable pancreatic cancer
- (2010) H. Chen et al. EJSO
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now